ARTELO BIOSCIENCES, INC. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE8-KARTELO BIOSCIENCES, INC.ARTLOct 9

   Artelo Biosciences faces MVLS rule uncertainty

   • SEC approved Nasdaq's $5M MVLS Rule on July 22, 2026.
   • 180 Nasdaq-listed companies, including Artelo, were below the threshold.
   • Temporary stay on the rule was announced on July 29, 2026.
2. ROUTINE8-KARTELO BIOSCIENCES, INC.ARTLAug 27

   Current report

3. ROUTINE10-Q/AARTELO BIOSCIENCES, INC.ATLEWAug 20

   Quarterly report (amended)

4. ROUTINESCHEDULE 13G/AARTELO BIOSCIENCES, INC.ATLEWAug 14

   Ownership stake disclosure by ARMISTICE CAPITAL, LLC (amended)

   ARMISTICE CAPITAL, LLC, filed by

5. ROUTINESCHEDULE 13G/AARTELO BIOSCIENCES, INC.ARTLAug 13

   Ownership stake disclosure by INTRACOASTAL CAPITAL, LLC (amended)

   INTRACOASTAL CAPITAL, LLC, filed by

6. NOTABLE10-QARTELO BIOSCIENCES, INC.ATLEWAug 12

   Quarterly report

7. ROUTINE4ARTELO BIOSCIENCES, INC.ATLEWJul 21

   6 insider filings

   Connie Matsui, insider filing for ATLEW

   Show all 6

   • 4Insider filing for ATLEWJul 21
   • 4Insider filing for ATLEWJul 21
   • 4Insider filing for ATLEWJul 21
   • 4Insider filing for ATLEWJul 21
   • 4Insider filing for ATLEWJul 21
   • 4Insider filing for ATLEWJul 21

   Connie Matsui, reporting

8. ROUTINE8-KARTELO BIOSCIENCES, INC.ATLEWJul 17

   Current report

9. ROUTINEDEFA14AARTELO BIOSCIENCES, INC.ARTLJul 16

   Additional proxy materials

10. ROUTINEDEFA14AARTELO BIOSCIENCES, INC.ARTLJul 2

    Additional proxy materials

11. ROUTINEPRER14AARTELO BIOSCIENCES, INC.ARTLJun 22

    PRER14A filing

12. ROUTINEARSARTELO BIOSCIENCES, INC.ATLEWJun 5

    Annual report to shareholders

13. ROUTINEDEFA14AARTELO BIOSCIENCES, INC.ATLEWJun 5

    Additional proxy materials

14. ROUTINEDEF 14AARTELO BIOSCIENCES, INC.ATLEWJun 5

    Proxy statement

15. ROUTINE8-KARTELO BIOSCIENCES, INC.ARTLMay 27

    Current report

16. ROUTINEPRE 14AARTELO BIOSCIENCES, INC.ATLEWMay 26

    Preliminary proxy statement

17. ROUTINE424B5ARTELO BIOSCIENCES, INC.ATLEWMay 26

    Securities offering

18. ROUTINEEFFECTARTELO BIOSCIENCES, INC.ATLEWMay 20

    Registration declared effective

19. ROUTINE424B5ARTELO BIOSCIENCES, INC.ATLEWMay 18

    Securities offering

20. ROUTINE8-KARTELO BIOSCIENCES, INC.ARTLMay 15

    Current report

21. ROUTINESCHEDULE 13GARTELO BIOSCIENCES, INC.ARTLMay 15

    Ownership stake disclosure by ARMISTICE CAPITAL, LLC

    ARMISTICE CAPITAL, LLC, filed by

22. NOTABLE10-QARTELO BIOSCIENCES, INC.ATLEWMay 14

    Quarterly report

23. ROUTINES-3/AARTELO BIOSCIENCES, INC.ATLEWMay 14

    Securities offering (amended)

24. ROUTINES-3ARTELO BIOSCIENCES, INC.ATLEWMay 4

    Securities offering

25. ROUTINE424B3ARTELO BIOSCIENCES, INC.ATLEWApr 16

    Securities offering

26. ROUTINEEFFECTARTELO BIOSCIENCES, INC.ATLEWApr 16

    Registration declared effective

27. NOTABLES-1ARTELO BIOSCIENCES, INC.ARTLApr 7

    Securities offering

28. ROUTINE8-KARTELO BIOSCIENCES, INC.ATLEWApr 7

    Current report

29. ROUTINEDARTELO BIOSCIENCES, INC.ATLEWApr 6

    Private placement notice

30. ROUTINESCHEDULE 13GARTELO BIOSCIENCES, INC.ARTLApr 3

    Ownership stake disclosure by INTRACOASTAL CAPITAL, LLC

    INTRACOASTAL CAPITAL, LLC, filed by

31. ROUTINEEFFECTARTELO BIOSCIENCES, INC.ATLEWMar 31

    Registration declared effective

32. ROUTINE8-KARTELO BIOSCIENCES, INC.ARTLMar 30

    Current report

33. ROUTINEDARTELO BIOSCIENCES, INC.ATLEWMar 27

    3 Form D filings

    Private placement notice

    Show all 3

    • DPrivate placement noticeMar 27
    • DPrivate placement noticeMar 27
    • DPrivate placement noticeMar 27
34. ROUTINERWARTELO BIOSCIENCES, INC.ATLEWMar 27

    RW filing

35. ROUTINE8-KARTELO BIOSCIENCES, INC.ARTLMar 26

    Current report

36. ROUTINEEFFECTARTELO BIOSCIENCES, INC.ARTLMar 26

    Registration declared effective

37. NOTABLES-1ARTELO BIOSCIENCES, INC.ARTLMar 24

    Securities offering

38. ROUTINES-1/AARTELO BIOSCIENCES, INC.ARTLMar 24

    Securities offering (amended)

39. ROUTINES-1/AARTELO BIOSCIENCES, INC.ARTLMar 23

    Securities offering (amended)

40. NOTABLES-1ARTELO BIOSCIENCES, INC.ARTLMar 20

    Securities offering

41. ROUTINE8-KARTELO BIOSCIENCES, INC.ARTLMar 18

    Current report

42. ROUTINE8-KARTELO BIOSCIENCES, INC.ATLEWMar 17

    Current report

43. ROUTINE8-KARTELO BIOSCIENCES, INC.ARTLMar 6

    Current report

Older filings on EDGAR